0,926  0,003  Antipsoriatic
0,921  0,005  Antiinflammatory
0,918  0,004  TNF expression inhibitor
0,878  0,002  Antiacne
0,877  0,003  AR expression inhibitor
0,880  0,008  Apoptosis agonist
0,841  0,010  Transcription factor NF kappa B inhibitor
0,806  0,006  15-Lipoxygenase inhibitor
0,797  0,004  Antioxidant
0,797  0,006  Radioprotector
0,795  0,005  Bone diseases treatment
0,779  0,005  Antiosteoporotic
0,774  0,005  CYP2C19 substrate
0,757  0,007  Chemoprotective
0,745  0,001  Retinoic acid receptor agonist
0,743  0,007  Prostate cancer treatment
0,750  0,014  CYP3A4 substrate
0,726  0,014  Teratogen
0,720  0,009  Chemopreventive
0,713  0,011  Carcinogenic
0,686  0,004  Macular degeneration treatment
0,693  0,015  Embryotoxic
0,681  0,004  Antipruritic, allergic
0,679  0,005  UDP-glucuronosyltransferase substrate
0,671  0,008  Proliferative diseases treatment
0,673  0,014  CYP2C9 substrate
0,644  0,002  ABCA1 expression enhancer
0,648  0,008  Nitric oxide antagonist
0,660  0,026  Antineoplastic (breast cancer)
0,638  0,008  Lipoprotein disorders treatment
0,648  0,018  Antileukemic
0,622  0,004  Liver fibrosis treatment
0,625  0,012  CYP1A2 substrate
0,613  0,009  Lipoxygenase inhibitor
0,599  0,009  Antineoplastic (brain cancer)
0,582  0,013  Hepatic disorders treatment
0,594  0,028  Cyclophilin D inhibitor
0,594  0,028  Antidiabetic
0,573  0,008  Hypolipemic
0,566  0,010  Hypoglycemic
0,556  0,005  Antiulcerative
0,559  0,017  CYP2D6 substrate
0,539  0,002  Keratolytic
0,542  0,008  UGT1A1 substrate
0,545  0,012  Free radical scavenger
0,548  0,019  Sensitization
0,528  0,001  Retinoic acid beta receptor agonist
0,526  0,006  Skin whitener
0,519  0,002  Alcohol dehydrogenase substrate
0,520  0,004  UGT2B7 substrate
0,517  0,001  Retinoic acid gamma receptor agonist
0,524  0,018  Antifungal
0,524  0,021  Cytotoxic
0,532  0,032  Antibacterial
0,511  0,035  Antiobesity
0,475  0,017  ICAM1 expression inhibitor
0,490  0,036  Immunosuppressant
0,456  0,006  Antiviral (Influenza)
0,453  0,005  Antiviral (Influenza A)
0,447  0,001  Retinoic acid receptor antagonist
0,448  0,007  Lipid peroxidase inhibitor
0,459  0,024  Mutagenic
0,436  0,002  Transcription factor AP-1 inhibitor
0,456  0,028  Caspase 3 stimulant
0,487  0,060  Antineoplastic (solid tumors)
0,442  0,027  Metabolic disease treatment
0,437  0,031  Cardioprotectant
0,404  0,002  Actinic keratosis treatment
0,400  0,001  Retinoid X beta receptor agonist
0,425  0,033  Antineoplastic (pancreatic cancer)
0,394  0,006  Glutathione S-transferase substrate
0,404  0,021  Vascular (periferal) disease treatment
0,392  0,012  UGT1A3 substrate
0,374  0,003  Growth stimulant
0,388  0,020  Eye irritation, high
0,363  0,002  Retinoic acid alpha receptor agonist
0,390  0,038  Antineoplastic (cervical cancer)
0,384  0,048  Antineoplastic (ovarian cancer)
0,373  0,037  NOS2 expression inhibitor
0,364  0,032  Antineoplastic (renal cancer)
0,338  0,010  CYP2B6 inhibitor
0,356  0,031  Antineoplastic (small cell lung cancer)
0,342  0,020  Skin irritative effect
0,319  0,003  Aldehyde dehydrogenase substrate
0,414  0,103  Caspase 9 stimulant
0,325  0,017  Interferon gamma antagonist
0,307  0,005  Age-related macular degeneration treatment
0,297  0,003  Ornithine decarboxylase inhibitor
0,347  0,065  Immunostimulant
0,312  0,032  Wound healing agent
0,285  0,010  Antineoplastic antibiotic
0,278  0,003  Adenylate cyclase stimulant
0,306  0,034  Abortion inducer
0,273  0,001  Retinoic acid receptor gamma antagonist
0,299  0,037  Antineoplastic enhancer
0,324  0,064  NOS3 expression inhibitor
0,314  0,056  UGT2B4 substrate
0,262  0,004  Hypercalcemia treatment
0,257  0,001  Retinoid X gamma receptor agonist
0,264  0,009  Retinopathy treatment
0,266  0,016  Aldehyde dehydrogenase inhibitor
0,262  0,016  LDLR expression enhancer
0,290  0,050  Antineoplastic (bladder cancer)
0,241  0,002  Retinoic acid alpha receptor antagonist
0,295  0,056  Antiprotozoal (Leishmania)
0,230  0,001  Retinoid X gamma receptor antagonist
0,282  0,063  Antineoplastic (glioma)
0,250  0,035  Antipruritic, non-allergic
0,255  0,044  VCAM1 expression inhibitor
0,285  0,076  Antineoplastic (melanoma)
0,282  0,072  Antihypoxic
0,306  0,096  Antineoplastic (lung cancer)
0,313  0,104  GST A substrate
0,264  0,058  DNA synthesis inhibitor
0,238  0,035  Antiviral (Herpes)
0,303  0,101  Antineoplastic (non-Hodgkin's lymphoma)
0,275  0,075  Antidiabetic (type 2)
0,217  0,019  Arachidonic acid antagonist
0,218  0,020  Neurotrophic factor
0,257  0,060  Antineoplastic (glioblastoma multiforme)
0,208  0,019  Retinoprotector
0,232  0,050  Neurotrophic factor enhancer
0,184  0,004  VCAM antagonist
0,247  0,068  Antineoplastic (lymphoma)
0,254  0,077  Antihypercholesterolemic
0,276  0,104  Apoptosis antagonist
0,211  0,039  Antineoplastic (squamous cell carcinoma)
0,202  0,030  Cocaine dependence treatment
0,202  0,036  UGT2B10 substrate
0,219  0,055  Hepatoprotectant
0,179  0,017  HDL-cholesterol increasing
0,160  0,002  Retinoic acid beta receptor antagonist
0,186  0,047  UGT2B9 substrate
0,185  0,048  Melanin inhibitor
0,161  0,032  Microtubule formation inhibitor
0,246  0,121  Antineoplastic (osteosarcoma)
0,141  0,019  UGT2B11 substrate
0,123  0,004  Retinoid X alpha receptor agonist
0,210  0,092  Antineoplastic (lymphocytic leukemia)
0,247  0,130  Vasodilator, peripheral
0,159  0,044  DNA polymerase I inhibitor
0,137  0,022  Antibiotic
0,228  0,115  Antineoplastic (multiple myeloma)
0,125  0,017  ATPase (Vacuolar H+) inhibitor
0,150  0,042  Ca2+-transporting ATPase inhibitor
0,112  0,004  Retinoid X receptor agonist
0,182  0,078  P-glycoprotein inhibitor
0,153  0,049  Farnesoid X receptor antagonist
0,163  0,063  Phospholipase A2 inhibitor
0,117  0,018  Thioredoxin reductase inhibitor
0,124  0,031  Androgen antagonist
0,199  0,110  Tumour necrosis factor alpha release inhibitor
0,149  0,060  Bone formation stimulant
0,123  0,036  Anabolic
0,164  0,077  UGT1A4 substrate
0,153  0,067  UGT2B15 substrate
0,172  0,087  Systemic lupus erythematosus treatment
0,169  0,089  Antihelmintic
0,180  0,102  Antiparasitic
0,077  0,004  HMG CoA reductase inhibitor
0,129  0,058  Cholesterol synthesis inhibitor
0,074  0,004  Retinoid X receptor antagonist
0,075  0,005  Parathyroid hormone antagonist
0,118  0,050  Electron transport complex I inhibitor
0,092  0,025  Hyperparathyroidism treatment
0,069  0,004  Vitamin D receptor antagonist
0,097  0,034  Na+ K+ transporting ATPase inhibitor
0,223  0,162  FMO1 substrate
0,063  0,004  Retinoid X alpha receptor antagonist
0,129  0,071  Antihemorrhagic
0,158  0,102  Amyloid beta aggregation inhibitor
0,069  0,015  Pregnane X receptor antagonist
0,068  0,017  Glucose-6-phosphate translocase inhibitor
0,180  0,129  Peptidyltransferase inhibitor
0,158  0,108  Antirickettsial
0,130  0,083  Protein kinase stimulant
0,083  0,036  Antitreponemal
0,045  0,003  Retinoid X beta receptor antagonist
0,153  0,113  Antieczematic atopic
0,210  0,173  GST M1-1 substrate
0,169  0,134  Cytostatic
0,138  0,103  Uterine stimulant
0,119  0,085  Papain-like protease (SARS coronavirus) inhibitor
0,091  0,061  SULT1E1 substrate
0,207  0,179  Sodium/bile acid cotransporter inhibitor
0,065  0,038  Antimycoplasmal
0,063  0,037  Heme oxygenase stimulant
0,198  0,177  CTGF expression inhibitor
0,051  0,031  Factor III inhibitor
0,174  0,155  Respiratory analeptic
0,160  0,141  UGT1A6 substrate
0,114  0,097  Antifungal enhancer
0,048  0,031  Microtubule stabilization
0,116  0,099  Antineoplastic (carcinoma)
0,073  0,057  SULT1A2 substrate
0,042  0,026  Kainate receptor agonist
0,027  0,012  CYP24 inhibitor
0,057  0,043  Lipocortins synthesis agonist
0,140  0,127  Phospholipase C inhibitor
0,020  0,007  Vitamin D receptor agonist
0,161  0,152  Antineoplastic (liver cancer)
0,084  0,078  DNA directed RNA polymerase inhibitor
0,033  0,028  Tubulin agonist
0,005  0,002  Vitamin D-like
0,051  0,050  Postcoital contraceptive

